LANXESS disinfectant kills Coronavirus SARS-CoV-2 in just 60 seconds

▴ disinfectant-kills-coronavirus-sars-cov2-just-60-seconds
Lanxess claims corona free surfaces in 60 seconds

Rely+On Virkon broad spectrum disinfectant, produced by specialty Chemicals Company LANXESS, demonstrates extremely rapid efficacy against the SARS-CoV-2 virus.

This is the finding of a recent study LANXESS commissioned through independent analysis laboratory Microbac Laboratories, Inc. in accordance with the U.S. Environmental Protection Agency (EPA) compliant test methods, for products intended for virucidal hard surface disinfection.

Rely+On Virkon achieved rapid and complete inactivation of the SARS-CoV-2 virus at a dilution ratio of 1:100 in just 60 seconds, and at an economical 1:600 in-use dilution with a 10 minute contact time.

Corresponding efficacy data has to be provided for disinfectants that claim to combat SARS-CoV-2. Microbac is one of the few testing laboratories worldwide that U.S. health authority CDC (Center for Disease Control) has certified to undertake such tests.“Neither a vaccine nor generally approved medications are currently available to us in the fight against the global coronavirus pandemic.So alongside social distancing and hand-washing, disinfection remains a highly important means to help prevent the spread of this life-threatening respiratory illness,” says Anneliese Bischof, Business Director Disinfection at LANXESS. “Right now, good hygiene cleaning and disinfection practices are more important than ever. The fact that Rely+On Virkon inactivates SARS-CoV-2 so quickly will help reassure people that the disinfectant product they are using is both fast and effective in practical use,” underlines Bischof.

Rely+On Virkon is a powder disinfectant concentrate diluted in water for application as a spray on hard surfaces and equipment (non-medical). It can therefore help to reduce the risk of cross-contamination from surfaces, door handles, tables or chairs during disinfection measures at public transport terminals, airports, hospitals, clinics, shopping malls, etc.

The LANXESS Material Protection Products business unit produces a wide range of scientifically based disinfection technologies under the Rely+On and Virkon brand.

LANXESS is a leading specialty chemicals company with sales of EUR 6.8 billion in 2019. The company currently has about 14,300 employees in 33 countries. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.

Tags : #Sars-Cov-2 #Lanxess #Disinfection #Microbac #CDC #RelyOn #Virkon

About the Author


Team Medicircle

Related Stories

16 Aug

National Health Authority and Maharashtra University of Health Sciences Forge Landmark Partnership to Advance Digital Health Education

Digital health is a catalyst for the modernization of India’s healthcare sector. Launched on September 27, 2021, the Ayushman Bharat Digital Mission (ABDM) aims to create a comprehensive digital health ecosystem through public-private collaboration.

View
04 Jul

Zika Virus Alert in Maharashtra: Government's Proactive Steps for Public Safety

Effective implementation of these measures, combined with continuous public education and robust health infrastructure, is crucial in the fight against Zika virus.

View
03 Jul

Infrastructure and Faculty Shortages Hamper New Medical Colleges in Maharashtra

Maharashtra currently has 25 government medical colleges offering a total of 3,950 MBBS seats. While the aim was to add 1,000 seats this year, the actual increase may only be around 300 or 400 if only a few colleges get approval.

View
15 Mar

Unanswered Questions: Tragic Death of Maharashtra Woman Despite Rabies Vaccination

Concerted efforts must be made to raise awareness about rabies prevention and ensure the effective administration of vaccines to prevent similar tragedies in the future.

View
15 Mar

Debunking Myths: ICMR Study Disproves COVID Vaccine Link to Sudden Deaths

As India continues its vaccination drive and global outreach, scientific rigor and data-driven policies remain paramount in safeguarding public health amidst the ongoing pandemic.

View
22 Nov

Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR Study

The findings highlight the importance of addressing traditional risk factors and lifestyle choices in understanding the occurrences of sudden unexplained deaths. As the world navigates through the complexities of COVID-19 and vaccination, this study contributes valuable insights to the broader conversation surrounding vaccine safety and its impact on public health.

View
08 Nov

Health on the Horizon: Maharashtra's Strategy to Combat Air Pollution Effect

The initiative holds paramount significance in addressing the immediate health impact of air pollution. By systematically tracking respiratory and coronary cases, authorities can identify trends, make informed decisions, and implement targeted interventions.

View
28 Oct

Spike in Cases of Auto-Immune Disorders like Rheumatoid Arthritis Post-COVID

It looks like the Coronavirus infection has altered our immune system, leading to a variety of health problems like arthritis. Many Covid patients are now coming to us complaining of joint and body pain. We are especially seeing a rise in cases of rheumatoid arthritis among women between 30-50 years of age.

View
27 Oct

Revolutionizing Nutrition in Tribal Education: AI-Based Machine Enhances Food Quality for Gadchiroli Children

As Maharashtra sets an example with this pilot project, the integration of artificial intelligence in nutritional initiatives could potentially transform the landscape of child health and education in tribal regions across the country.

View
20 Oct

Behind the Scenes: Maharashtra's Journey Towards a TB-Free Future

The state's healthcare system faces pressing challenges, particularly the shortage of essential medicines for MDR-TB patients. Bridging this gap requires not only the establishment of training facilities but also a simultaneous commitment to addressing the fundamental issues damaging TB treatment and prevention.

View

-Advertisements-




Trending Now

World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025
Is long-acting HIV treatment as good as taking daily pills?March 31, 2025
Right to safe abortion cannot be dislocated from human rightsMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025